One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Pharmacokinetics and Safety of Oral Pyrophosphate in Systemic Sclerosis Patients—A Pilot Study
doi : 10.1002/acr2.70036
Patient-Reported Factors Influencing Clinical Trial Participation: An In-depth Analysis of Patients With Lupus and Rheumatoid Arthritis
doi : 10.1002/acr2.70035
Long-Term Health Consequences of SARS-CoV-2- Trigger for Still Disease in Adults
doi : 10.1002/acr2.70042
Cardiac Magnetic Resonance Imaging Findings in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitides: A Systematic Review
doi : 10.1002/acr2.70026
Correction to “Multifactorial Induction of a “Scleroderma-Like Pattern� Without Underlying Connective Tissue Disease: Diagnostic and Therapeutic Implications�
doi : 10.1002/acr2.70028
Safety of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Combined Data From Three Clinical Trials
doi : 10.1002/acr2.70001
Mass-Forming Variants in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Diagnostic Complexities in Granulomatous Disease. A Case Report
doi : 10.1002/acr2.70038
Osteoclastogenesis in Patients With Systemic Sclerosis With and Without Calcinosis Cutis
doi : 10.1002/acr2.70029
The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis
doi : 10.1002/acr2.70034
